Skip to content

Comparision of the border of colorectal adenomatous lesions between un derwater and under-gel

Comparision of the border of colorectal adenomatous lesions between un derwater and under-gel

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs062220033
Enrollment
72
Registered
2022-06-10
Start date
2022-06-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal adenoma colorectal adenoma

Interventions

Endoscopic observation should be performed in Underwater and Under-gel according to the preliminary allocation. After imaging, aspirate saline or Viscoclear as much as possible, and perform the next
Colonoscopy
Under-gel EMR

Sponsors

Yamasaki Yasushi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Patients with non-pedunculated adenomatous colorectal lesions of 6 mm or more but less than 20 mm on colonoscopy performed within the past 18 months 2) The most proximal lesion, if there are multiple lesions between 6mm and 20mm 3)Patients who are 20 years of age or older at the time of obtaining consent. 4)Patients who have obtained written consent of t heir own free will with full understanding after receiving sufficient explanation for participation in this study.

Exclusion criteria

Exclusion criteria: 1)Patients with suspected invasive cancer (submu cosa or deeper) 2)Patients with Inflammatory Bowel Disease (IBD) 3)Patients who cannot undergo bowel 4) Patients with a history of hypersensitivity to any ingredient of Viscoclear 5) Patients deemed ineligible by the researchers

Design outcomes

Primary

MeasureTime frame
the visibility of tumor borders in underwater and under-gel

Secondary

MeasureTime frame
(1)the visibility of tumor borders in underwater and under-gel (subjective evaluation in 4 levels) (2)color differences by bowel preparation (3)Pathological evaluation and adverse events

Contacts

Public ContactJunki Toyosawa

Okayama University Hospital

vy8nw7@bma.biglobe.ne.jp+81-862357219

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 21, 2026